Richard Steinhart
Director Financiero/CFO en BIOXCEL THERAPEUTICS, INC. .
Fortuna: 12 487 $ al 31/05/2024
Cargos activos de Richard Steinhart
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 08/11/2013 | - |
| Independent Dir/Board Member | 08/11/2013 | - | |
| ATOSSA THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/03/2014 | - |
| Independent Dir/Board Member | 01/03/2014 | - | |
| BIOXCEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2017 | - |
| Director Financiero/CFO | 01/10/2017 | - |
Historial de carrera de Richard Steinhart
Antiguos cargos conocidos de Richard Steinhart.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Director Financiero/CFO | 14/10/2015 | 01/04/2017 |
| STRATA SKIN SCIENCES, INC. | Director Financiero/CFO | 24/04/2006 | 31/12/2013 |
| Secretario Corporativo | 24/04/2006 | 31/12/2013 | |
| Treasurer | 24/04/2006 | 31/12/2013 | |
| TG THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/07/2004 | 01/01/2012 |
| Independent Dir/Board Member | 27/06/2011 | 01/01/2012 | |
| Forest Street Capital, LLC | Corporate Officer/Principal | 01/05/1992 | 24/04/2006 |
| EMISPHERE TECHNOLOGIES, INC. | Director Financiero/CFO | 01/05/1991 | 01/05/1992 |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Director Financiero/CFO | 01/01/1991 | 02/01/1992 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formación de Richard Steinhart.
| Pace University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 13 |
Operativa
| Director of Finance/CFO | 6 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectorial
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| Forest Street Capital, LLC | |
| SAE Ventures | |
| MELA Sciences Inc. |
- Bolsa de valores
- Insiders
- Richard Steinhart
- Experiencia
